Institutional Ownership
Cellectis S A
CUSIP 15117K103SPON ADSCLLSQ1 2026
13D / 13G Filings
21
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
44.0%
Max % of class reported
Institutional Holders
31
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
21 filings · latest Dec 12, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Dec 12, 2025 | Bpifrance Participations S.A. | 13D/A | 11.1% | — | SEC |
| 2 | Feb 11, 2025 | Long Focus Capital Management, LLC | 13G/A | 4.6% | 4.62M | SEC |
| 3 | Jan 30, 2025 | Bpifrance Participations S.A. | 13D/A | 13.1% | — | SEC |
| 4 | Jan 24, 2025 | Astrazeneca PLC | 13D/A | 44.0% | — | SEC |
| 5 | May 21, 2024 | Bpifrance Participations SA | 13D/A | 5.9% | 5.87M | SEC |
| 6 | Feb 14, 2024 | Long Focus Capital Management, LLC | 13G/A | 6.3% | 4.49M | SEC |
| 7 | Feb 14, 2024 | Pfizer Inc | 13G/A | 3.9% | 2.79M | SEC |
| 8 | Dec 5, 2023 | Baillie Gifford & Co | 13G/A | 3.1% | 2.19M | SEC |
| 9 | Nov 16, 2023 | Astrazeneca PLC | 13D/A | 22.4% | 16.00M | SEC |
| 10 | Nov 13, 2023 | Bpifrance Participations SA | 13D/A | 8.2% | 5.87M | SEC |
11 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cellectis S A.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | B Group, Inc. | 3.28M | $10.40M |
| 2 | Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 3.18M | $10.08M |
| 3 | Long Focus Capital Management, LLC | 2.74M | $8.70M |
| 4 | Blackrock, Inc. | 341.5K | $1.08M |
| 5 | Nomura Asset Management International Inc. | 226.9K | $719.0K |
| 6 | Morgan Stanley | 86.8K | $275.1K |
| 7 | Lpl Financial LLC | 84.3K | $267.4K |
| 8 | Susquehanna International Group, LLP | 65.9K | $209.0K |
| 9 | Citadel Advisors LLC | 44.3K | $140.5K |
| 10 | Marshall Wace, LLP | 41.1K | $130.3K |